HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Zhen Gu Selected Research

Insulin (Novolin)

1/2023Material design for oral insulin delivery.
1/2023Glucose-Responsive Charge-Switchable Lipid Nanoparticles for Insulin Delivery.
12/2022Glucose-responsive microneedle patch for closed-loop dual-hormone delivery in mice and pigs.
11/2022Microneedle Patches Loaded with Nanovesicles for Glucose Transporter-Mediated Insulin Delivery.
10/2022Shrinking Fabrication of a Glucose-Responsive Glucagon Microneedle Patch.
1/2021Injectable Biodegradable Polymeric Complex for Glucose-Responsive Insulin Delivery.
1/2021Roadmap on nanomedicine.
1/2021Developing Insulin Delivery Devices with Glucose Responsiveness.
11/2020Dual self-regulated delivery of insulin and glucagon by a hybrid patch.
7/2020Engineered PD-L1-Expressing Platelets Reverse New-Onset Type 1 Diabetes.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Zhen Gu Research Topics

Disease

107Neoplasms (Cancer)
04/2024 - 12/2009
15Inflammation (Inflammations)
04/2024 - 05/2011
15Infections
12/2023 - 05/2014
13Hypoglycemia (Reactive Hypoglycemia)
12/2022 - 07/2015
10Type 2 Diabetes Mellitus (MODY)
11/2022 - 01/2018
9Melanoma (Melanoma, Malignant)
11/2023 - 01/2016
8Neoplasm Metastasis (Metastasis)
07/2023 - 01/2018
8Hypoxia (Hypoxemia)
01/2019 - 07/2015
6Wounds and Injuries (Trauma)
04/2024 - 01/2018
6Type 1 Diabetes Mellitus (Autoimmune Diabetes)
12/2023 - 08/2013
6Hyperglycemia
01/2023 - 07/2015
5Pain (Aches)
04/2024 - 05/2014
4Hepatocellular Carcinoma (Hepatoma)
09/2023 - 01/2013
4Autoimmune Diseases (Autoimmune Disease)
01/2023 - 11/2014
3Peripheral Nerve Injuries
04/2024 - 08/2023
3Gallbladder Neoplasms (Gallbladder Cancer)
02/2024 - 01/2022
3Breast Neoplasms (Breast Cancer)
11/2023 - 01/2017
3Diabetes Mellitus
01/2023 - 05/2013
2Thrombosis (Thrombus)
03/2024 - 01/2019
2Pancreatic Neoplasms (Pancreatic Cancer)
03/2024 - 09/2023
2Cardiovascular Diseases (Cardiovascular Disease)
01/2024 - 01/2022
2Cytokine Release Syndrome
09/2023 - 07/2020
2Bites and Stings (Sting)
04/2023 - 12/2021
2Colitis
02/2023 - 04/2016
2Leukemia
03/2022 - 01/2019
2Glioblastoma (Glioblastoma Multiforme)
10/2021 - 10/2016
2Alopecia (Baldness)
01/2021 - 01/2019
2Stroke (Strokes)
01/2021 - 10/2016
2Obesity
01/2020 - 01/2017
2Colonic Neoplasms (Colon Cancer)
02/2019 - 11/2017

Drug/Important Bio-Agent (IBA)

24Insulin (Novolin)FDA Link
01/2023 - 08/2013
20Glucose (Dextrose)FDA LinkGeneric
04/2024 - 05/2013
12HydrogelsIBA
04/2024 - 12/2017
12Blood Glucose (Blood Sugar)IBA
01/2023 - 08/2013
11Proteins (Proteins, Gene)FDA Link
03/2024 - 07/2011
9Peptides (Polypeptides)IBA
03/2024 - 04/2013
9Immune Checkpoint InhibitorsIBA
12/2021 - 01/2017
7Chimeric Antigen ReceptorsIBA
04/2024 - 08/2017
6Therapeutic UsesIBA
04/2024 - 09/2017
6CytokinesIBA
03/2024 - 01/2016
6EnzymesIBA
01/2023 - 08/2013
6LigandsIBA
11/2022 - 10/2014
5Reactive Oxygen Species (Oxygen Radicals)IBA
02/2024 - 01/2019
5Cancer VaccinesIBA
11/2023 - 01/2020
5VaccinesIBA
11/2023 - 01/2018
5Biocompatible Materials (Biomaterials)IBA
01/2022 - 08/2017
5PolymersIBA
01/2022 - 05/2014
5DNA (Deoxyribonucleic Acid)IBA
08/2020 - 09/2011
5AntigensIBA
01/2020 - 05/2018
5NanocapsulesIBA
11/2018 - 08/2011
4NitrogenIBA
03/2024 - 12/2020
4ProdrugsIBA
11/2023 - 01/2017
4AcidsIBA
04/2023 - 10/2014
4Glucagon (Glukagon)FDA Link
12/2022 - 01/2017
4B7-H1 AntigenIBA
01/2021 - 01/2018
4Doxorubicin (Adriamycin)FDA LinkGeneric
12/2020 - 05/2014
3LipidsIBA
03/2024 - 08/2014
3Messenger RNA (mRNA)IBA
03/2024 - 11/2018
3Neoplasm Antigens (Tumor Antigens)IBA
02/2023 - 01/2019
3Caspase 3 (Caspase-3)IBA
11/2022 - 12/2009
3Hyaluronic Acid (Hyaluronan)IBA
01/2021 - 07/2015
3AntibodiesIBA
01/2021 - 01/2019
2Analgesics (Analgesic Drugs)IBA
04/2024 - 03/2015
2IonsIBA
11/2023 - 12/2021
2MetalsIBA
11/2023 - 04/2023
2BoronIBA
09/2023 - 01/2023
2Antiviral Agents (Antivirals)IBA
07/2023 - 03/2019
2vadimezanIBA
04/2023 - 01/2021
2InterferonsIBA
04/2023 - 12/2021
2Phosphates (Orthophosphate)IBA
04/2023 - 02/2019
2OligodeoxyribonucleotidesIBA
04/2023 - 10/2016
2Pancreatic Ribonuclease (Ribonuclease A)IBA
11/2022 - 11/2018
2Glycoproteins (Glycoprotein)IBA
08/2022 - 01/2013
2FibrinIBA
10/2021 - 01/2019
2Nucleic AcidsIBA
01/2021 - 08/2020
2fosbretabulin (combretastatin A4)IBA
11/2019 - 02/2019
2Cisplatin (Platino)FDA LinkGeneric
02/2019 - 01/2017
2Oxygen (Dioxygen)IBA
01/2019 - 01/2017
2Neuroprotective AgentsIBA
01/2019 - 10/2016
2Drug CarriersIBA
01/2017 - 07/2015

Therapy/Procedure

70Therapeutics
04/2024 - 07/2011
32Immunotherapy
11/2023 - 01/2016
9Injections
11/2023 - 05/2014
8Drug Therapy (Chemotherapy)
01/2023 - 12/2014
3Precision Medicine
11/2023 - 05/2015
3Photothermal Therapy
01/2023 - 01/2018
3Cell- and Tissue-Based Therapy (Cell Therapy)
01/2023 - 01/2018
3Intravenous Administration
01/2023 - 01/2021
2Electroacupuncture
04/2024 - 03/2015
2Biological Therapy
09/2023 - 01/2018
2Cutaneous Administration
09/2023 - 01/2017
2Radiotherapy
01/2023 - 01/2020
2Photochemotherapy (Photodynamic Therapy)
01/2023 - 07/2021
2Phototherapy (Light Therapy)
01/2023 - 01/2020
2Lasers (Laser)
11/2022 - 01/2018
2Stents
10/2022 - 06/2019
2Electrodes (Electrode)
01/2022 - 01/2013
2Immunomodulation
01/2022 - 03/2019
2Topical Administration
01/2021 - 08/2020
2Glycemic Control
04/2020 - 01/2019